http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107354239-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_54d14d5d0675d4627c25bc3c85df29ca |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-166 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
filingDate | 2017-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_856ae47bd8e510c4ec9b576d1d469248 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b7fc3419dae575f2a1137b41573be19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd7c1c4ee7dddeff38fdb75bf795e101 |
publicationDate | 2017-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107354239-A |
titleOfInvention | A multiplex fluorescent quantitative PCR method and kit for detecting Epstein-Barr virus |
abstract | The invention discloses a multiplex fluorescent quantitative PCR method and a kit for detecting EB virus, the kit includes detection primer pairs and probes for detecting EBNA1, Bam HI-W gene and human internal reference gene, the sequences of which are sequentially shown as SEQ ID NO: 1-9. The present invention integrates the advantages of the above-mentioned EBNA1 gene and Bam HI-W gene and adds the method of multiple fluorescence quantitative PCR with the human internal reference gene, that is, uses the internal reference gene to detect the feasibility of the DNA extraction effect of the specimen, and uses the double target gene to realize the The precise qualitative and quantitative analysis of Epstein-Barr virus has higher sensitivity and specificity compared with existing commercial kits, and the fluorescent quantitative PCR technology of the present invention has the advantages of simple operation, short time, wide source of reagent consumables, low cost, Fluorescent PCR system has the advantages of strong reagent connectivity and has great application prospects. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111363825-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021013972-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112430685-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109929949-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113502354-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109666763-A |
priorityDate | 2017-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.